推荐同事 机构合作 中文 繁體中文 English 한국어 日本語 Português Español

美国ACCDON公司旗下品牌

021-33361733，021-33632861

chinasupport@letpub.com

登录 注册 新注册优惠

Four-Year Follow-Up of Trastuzumab Plus Adjuvant Chemotherapy for Operable Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer: Joint Analysis …

[HTML] from ascopubs.orgEA Perez, EH Romond, VJ Suman… - Journal of Clinical …, 2011 - jco.ascopubs.org
Purpose Trastuzumab is a humanized monoclonal antibody against the human epidermal growth
factor receptor 2 (HER2). The clinical benefits of adjuvant trastuzumab have been demonstrated
in interim analyses of four large trials. Initial data of the combined analysis of the North ...

RIBBON-1: Randomized, double-blind, placebo-controlled, phase III trial of chemotherapy with or without bevacizumab for first-line treatment of human epidermal …

[HTML] from jcojournal.orgNJ Robert, V Diéras, J Glaspy… - Journal of Clinical …, 2011 - jcojournal.org
Presented in part at the 45th Annual Meeting of the American Society for Clinical Oncology, May
29-June 2, 2009, Orlando, FL, and at the 15th Congress of the European Cancer Organisation
and 34th Congress of the European Society for Medical Oncology Multidisciplinary ...
Cited by 165 - Related articles - All 7 versions

Iniparib plus chemotherapy in metastatic triple-negative breast cancer

[PDF] from medpagetoday.comJ O'Shaughnessy, C Osborne… - … England Journal of …, 2011 - Mass Medical Soc
From Baylor Charles A. Sammons Cancer Center (JO, CO, JEP), US Oncology (JO, CO, JEP,
MY, DP), and Texas Oncology, Dallas (JO, CO, JEP) — all in Dallas; Cancer Centers of North
Caro- lina, Raleigh (MY); Texas Oncology Can- cer Center, Austin (DP); and BiPar Sci- ...
Cited by 59 - Related articles - All 7 versions

Feasibility of a lifestyle intervention for ovarian cancer patients receiving adjuvant chemotherapy.

VE von Gruenigen, HE Frasure… - Gynecologic …, 2011 - ncbi.nlm.nih.gov
OBJECTIVES: This study aimed to assess the feasibility of a lifestyle intervention for promoting
physical activity (PA) and diet quality during adjuvant chemotherapy for ovarian cancer.
METHODS: Patients were enrolled post-operatively and received PA and nutrition ...
Cited by 2

Primary gastric Hodgkin's lymphoma: favourable outcome following multi-agent chemotherapy without surgical intervention

KI Quintyne, E Mulcahy, F Wallis… - BMJ Case …, 2011 - casereports.bmj.com
The authors report the case of a 51-year-old man who presented with left-sided abdominal pain
and weight loss associated with drenching night sweats. Preliminary blood tests yielded no specific
cause for his symptoms, but abdominal ultrasound revealed multiple hepatic lesions and ...
Related articles - All 2 versions

联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们

© 2010-2024 中国: LetPub上海分公司    网站备案号：沪ICP备10217908号-1    沪公网安备号：31010402006960

增值电信业务经营许可证：沪B2-20211595

礼翰商务信息咨询（上海）有限公司      办公地址：上海市徐汇区漕溪北路88号圣爱大厦1803室

United States: Tel: 1-781-202-9968 Address: 400 5th Ave, Suite 530, Waltham, Massachusetts 02451